On a full-year basis, revenue from operations for FY26 grew 18.9 percent year-on-year to Rs 827.87 crore compared to Rs 696.48 crore in FY25
The Establishment Inspection Report came following closure of a product- specific pre-approval inspection from March 2 to March 7, 2026
AAV vectors are widely used in gene therapy for their strong therapeutic potential
The acquisition marks Anupam Rasayan’s strategic entry into the pharmaceutical formulations segment
The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks
Surya to lead medical governance, patient safety, clinical excellence, and quality assurance initiatives across the organization’s pan-India network.
Clears major obesity endpoints at 80 weeks
The approval has been secured in partnership with Yabao Pharmaceuticals, a major player in China’s paediatric medicine segment
Dr. Upadhyay brings over 25 years of global leadership experience across life sciences, regulated manufacturing, diagnostics, and research-led environments
In his new role, he will lead the growth strategy for the group’s operations, including Apothecon Pharmaceuticals in India and Navinta LLC in the United States
Subscribe To Our Newsletter & Stay Updated
